Detalhe da pesquisa
1.
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
Mol Cancer
; 21(1): 20, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042524
2.
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
J Transl Med
; 20(1): 159, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382857
3.
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy.
Pharmacol Res
; 182: 106323, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752358
4.
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma.
J Transl Med
; 18(1): 473, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33302981
5.
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).
BMC Cancer
; 18(1): 552, 2018 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29747595
6.
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
BMC Cancer
; 16(1): 905, 2016 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863476
7.
Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study.
J Surg Oncol
; 114(2): 246-53, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156580
8.
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy.
J Transl Med
; 13: 26, 2015 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623468
9.
Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?
Exp Cell Res
; 321(2): 240-7, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384475
10.
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
Front Immunol
; 15: 1369531, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38799429
11.
Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.
BMC Complement Altern Med
; 13: 199, 2013 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23899130
12.
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.
Cancers (Basel)
; 15(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900333
13.
Cervical cancer benefits from trabectedin combination with the ß-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.
Front Cell Dev Biol
; 11: 1178316, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384250
14.
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
J Exp Clin Cancer Res
; 42(1): 251, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37759291
15.
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Eur J Cancer
; 191: 113246, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549531
16.
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Eur J Cancer
; 187: 25-35, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099946
17.
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients.
Sci Rep
; 12(1): 20366, 2022 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437296
18.
Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?
Oncologist
; 16(7): 1040-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659611
19.
Cell fusion and hyperactive osteoclastogenesis in multiple myeloma.
Adv Exp Med Biol
; 714: 113-28, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21506010
20.
[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. / Alla ricerca di nuovi marcatori in osteo-oncologia: la fosfatasi acida tartrato-resistente nella malattia ossea mielomatosa.
Recenti Prog Med
; 102(2): 88-95, 2011 Feb.
Artigo
em Italiano
| MEDLINE | ID: mdl-21513124